ATP6AP1 and breast carcinoma: To investigate the connection between ATP6AP1 expression and clinicopathological parameters of patients in the TCGA-BRCA cohort, based on the median value, we separated breast cancer samples into two groups: high expression and low expression (Supplementary Table S4).